Lupin Limited ('the Company') having planned to enter into a Business Transfer Agreement ('BTA') with Lupin Manufacturing Solutions Limited ('LMSL'), wholly owned subsidiary of the Company, to carve out two Active Pharmaceutical Ingredients manufacturing sites situate at Dabhasa and Visakhapatnam and select R&D operations, including fermentation, at Lupin Research Park, Pune. Today i.e. October 16, 2023, the Company has entered into a BTA with LMSL in connection with the carve out.
Shares of Lupin Limited was last trading in BSE at Rs. 1198.20 as compared to the previous close of Rs. 1188.90. The total number of shares traded during the day was 27296 in over 2592 trades.
The stock hit an intraday high of Rs. 1201.10 and intraday low of 1185.95. The net turnover during the day was Rs. 32646223.00.